“ Treatment With Dasatinib or Nilotinib in Chronic Myeloid Leukemia Patients Who Failed to Respond to Two Previously Administered Tyrosine Kinase Inhibitors - a Single Center Experience ”. Clinics 70, no. 8 (August 1, 2015): 550–555. Accessed May 12, 2024. https://www.revistas.usp.br/clinics/article/view/102011.